Volumetric Optical Imaging and Quantitative Analysis of Age-Related Changes in Anterior Human Vitreous.
Adolescent
Adult
Aged
Aging
Axial Length, Eye
/ diagnostic imaging
Child
Contrast Sensitivity
/ physiology
Cross-Sectional Studies
Female
Humans
Lens, Crystalline
/ diagnostic imaging
Male
Middle Aged
Myopia
/ diagnosis
Reproducibility of Results
Tomography, Optical Coherence
/ methods
Vitreous Body
/ diagnostic imaging
Young Adult
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 04 2021
01 04 2021
Historique:
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
6
10
2021
Statut:
ppublish
Résumé
The purpose of this study was to characterize age-related changes in anterior human vitreous with 3-D swept source optical coherence tomography (SS-OCT) and evaluate associations with axial length (AL) and contrast sensitivity function (CSF). There were 49 phakic eyes in 49 patients (40.0 ± 19.3 years) had 3-D volumetric scanning of the lens and retrolental vitreous with SS-OCT at 1050 nm. OCT-derived indices of vitreous optical density (VOD), vitreous opacification ratio (VOR), and lens optical density (LOD) were correlated with AL and double-pass assessment of retinal point spread function (Objective Scatter Index [OSI]). CSF was measured using an adaptive-optics visual simulator (area under log-log contrast sensitivity function [AULCSF]). Vitreous SS-OCT detected gel vitreous, liquefied lacunae, Berger's space, retrolental laminae, and fibrous opacifications. VOD, VOR, and LOD showed high reproducibility (intraclass correlation coefficients 0.968, 0.975, and 0.998, respectively). VOD was highly correlated with VOR (Pearson's R = 0.96, P < 0.000001). VOD, VOR, and LOD correlated with age (R = 0.48, 0.58, and 0.85, P < 0.001 for each). VOR and LOD correlated with OSI (R = 0.36, P = 0.0094, and R = 0.36, P = 0.0096, respectively). VOR correlated negatively with AULCSF (R = -0.53, P < 0.00009), which was related to OSI. Myopic eyes had higher OSI than nonmyopic eyes (P = 0.0121), consistent with correlation between OSI and AL (R = 0.37, P = 0.0091). Multivariable regression confirmed these findings. SS-OCT visualized microstructural features of anterior human vitreous, where opacification is associated with increased light scattering and CSF degradation. SS-OCT enables high-resolution optical evaluation of vitreous opacities.
Identifiants
pubmed: 33929483
pii: 2772521
doi: 10.1167/iovs.62.4.31
pmc: PMC8088225
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
31Références
J Refract Surg. 2015 Mar;31(3):188-94
pubmed: 25751836
Am J Ophthalmol. 2008 Oct;146(4):496-500
pubmed: 18639219
Transl Vis Sci Technol. 2020 Jan 29;9(1):2
pubmed: 32509437
Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):919-925
pubmed: 29536170
Exp Eye Res. 2002 Feb;74(2):173-80
pubmed: 11950227
Am J Ophthalmol. 2021 Apr;224:246-253
pubmed: 32950508
PLoS One. 2014 Jul 18;9(7):e102950
pubmed: 25036044
J Cataract Refract Surg. 2004 Jul;30(7):1598-9
pubmed: 15210251
Ophthalmology. 2009 Aug;116(8):1436-43
pubmed: 19500847
J Biomed Opt. 2004 Jan-Feb;9(1):38-46
pubmed: 14715056
Am J Ophthalmol. 2016 Dec;172:7-12
pubmed: 27633841
Ophthalmology. 2005 Nov;112(11):2022-9
pubmed: 16183126
Prog Retin Eye Res. 2020 Nov;79:100847
pubmed: 32151758
Biomed Opt Express. 2018 Jul 24;9(8):3821-3833
pubmed: 30338158
Ophthalmology. 1996 Feb;103(2):205-6
pubmed: 8594502
Br J Ophthalmol. 2014 Jul;98(7):994-7
pubmed: 24659354
Exp Eye Res. 2001 Dec;73(6):859-66
pubmed: 11846516
Ocul Oncol Pathol. 2020 Jan;6(1):3-9
pubmed: 32002397
Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1041-6
pubmed: 15037566
Am J Ophthalmol. 2010 Apr;149(4):641-50
pubmed: 20138610
Ophthalmology. 2018 Sep;125(9):1372-1383
pubmed: 29631900
Eye (Lond). 2008 Oct;22(10):1251-6
pubmed: 18292783
J Vis. 2009 Mar 25;9(3):19.1-10
pubmed: 19757958
Eye (Lond). 2021 Jan;35(1):351-352
pubmed: 32055017
J Cataract Refract Surg. 2019 Jul;45(7):903-909
pubmed: 31262480
J Cataract Refract Surg. 2004 Oct;30(10):2232-4
pubmed: 15474843
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):897-903
pubmed: 29435589
Retina. 2019 Sep;39(9):1732-1741
pubmed: 29912094
Biomed Opt Express. 2012 Nov 1;3(11):2733-51
pubmed: 23162712
Invest Ophthalmol Vis Sci. 2004 Jan;45(1):77-85
pubmed: 14691157
Am J Ophthalmol. 2014 Feb;157(2):397-404.e2
pubmed: 24439443
Arch Ophthalmol. 2008 May;126(5):744; author reply 744
pubmed: 18474803
Prog Retin Eye Res. 2010 Nov;29(6):580-95
pubmed: 20621195
J Cataract Refract Surg. 2019 Jan;45(1):87-93
pubmed: 30309774
Graefes Arch Clin Exp Ophthalmol. 1987;225(2):89-93
pubmed: 3583000
Ophthalmol Retina. 2020 Feb;4(2):148-153
pubmed: 31864940
JAMA Ophthalmol. 2014 Sep;132(9):1148-50
pubmed: 25010436
Eye (Lond). 2002 Jul;16(4):429-39
pubmed: 12101450
J Cataract Refract Surg. 2014 May;40(5):716-21
pubmed: 24767907
Surv Ophthalmol. 2016 Mar-Apr;61(2):211-27
pubmed: 26679984
PLoS One. 2011 Feb 04;6(2):e16823
pubmed: 21326868
Ophthalmology. 2016 Feb;123(2):248-254
pubmed: 26545319
J Cataract Refract Surg. 1999 Jul;25(7):981-4
pubmed: 10404376
Arch Soc Esp Oftalmol. 2019 Oct;94(10):471-477
pubmed: 31378388
Graefes Arch Clin Exp Ophthalmol. 2008 Mar;246(3):329-32
pubmed: 18228032
Ophthalmology. 2014 Sep;121(9):1706-14
pubmed: 24835759
Antioxidants (Basel). 2019 Dec 20;9(1):
pubmed: 31861871
Science. 1984 Jan 27;223(4634):399-400
pubmed: 6318321
Retina. 2015 Jun;35(6):1240-6
pubmed: 25650709
Ophthalmol Retina. 2018 Sep;2(9):881-887
pubmed: 31047219
Graefes Arch Clin Exp Ophthalmol. 2004 Aug;242(8):690-8
pubmed: 15309558
Invest Ophthalmol Vis Sci. 2015 Jan 22;56(3):1611-7
pubmed: 25613948